» Articles » PMID: 31389267

Effects of Rosiglitazone/PHBV Drug Delivery System on Postoperative Fibrosis in Rabbit Glaucoma Filtration Surgery Model

Overview
Journal Drug Deliv
Specialty Pharmacology
Date 2019 Aug 8
PMID 31389267
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study is to investigate the effects and toxicities of poly(3-hydroxybutyric acid--3-hydroxyvaleric acid) (PHBV)-loading rosiglitazone on preventing scar formation after glaucoma filtration surgery (GFS) in the rabbit model. Rosiglitazone/PHBV drug delivery system was prepared via electrospinning. Release behavior of RSG/PHBV membrane was evaluated by high-performance liquid chromatography. The different concentration membranes were implanted under the conjunctiva of the rabbit's eyes (RSG/PHBV groups). Also, MMC-soaked sponges were placed under the conjunctiva of the eyes (positive group) for 3 min. Intraocular pressures and bleb features were then assessed for 4 weeks postoperative. Bleb sections were stained with HE, Masson's trichrome and α smooth muscle action (αSMA) immunohistochemistry. The protein expression of collagen I, αSMA, and connective tissue growth factor in the bleb area were then quantified. The following results were observed: (1) the concentration of rosiglitazone would not affect the morphology of RSG/PHBV membrane. (2) RSG/PHBV membrane would effective and safety prevent the formation of fibrosis after GFS in the rabbit model. Implantation of RSG/PHBV membrane prevents scar formation after GFS. What's more, it ameliorated toxicity to conjunctiva and cornea compared with the placement of MMC. The RSG/PHBV membrane would be a more effectivity and safer strategy than MMC.

Citing Articles

A novel adjustable PHBV basement film for enhancing the efficacy of glaucoma surgery by inhibiting scar formation.

Zhou D, Zhu W, Liu H, Zhang F, Zhou X, Zhang X Mater Today Bio. 2024; 24:100922.

PMID: 38226011 PMC: 10788518. DOI: 10.1016/j.mtbio.2023.100922.


Quercetin modified electrospun PHBV fibrous scaffold enhances cartilage regeneration.

Chen W, Li Y, Huang Y, Dai Y, Xi T, Zhou Z J Mater Sci Mater Med. 2021; 32(8):92.

PMID: 34374884 PMC: 8354921. DOI: 10.1007/s10856-021-06565-z.


Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners.

Oouchi Y, Watanabe M, Ida Y, Ohguro H, Hikage F Int J Mol Sci. 2021; 22(14).

PMID: 34298955 PMC: 8307967. DOI: 10.3390/ijms22147335.


Knockdown of FAM225B inhibits the progression of the hypertrophic scar following glaucoma surgery by inhibiting autophagy.

Ma X, Liu L Mol Med Rep. 2021; 23(3).

PMID: 33495826 PMC: 7821338. DOI: 10.3892/mmr.2021.11843.


Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy.

Chen H, Qian Z, Zhang S, Tang J, Le Fang , Jiang F Redox Biol. 2020; 38:101774.

PMID: 33152664 PMC: 7645269. DOI: 10.1016/j.redox.2020.101774.

References
1.
Picht G, Grehn F . Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol. 1998; 9(2):2-8. DOI: 10.1097/00055735-199804000-00002. View

2.
Oshima Y, Sakamoto T, Nakamura T, Tahara Y, Goto Y, Ishibashi T . The comparative benefits of glaucoma filtering surgery with an electric-pulse targeted drug delivery system demonstrated in an animal model. Ophthalmology. 1999; 106(6):1140-6. DOI: 10.1016/S0161-6420(99)90249-X. View

3.
Anand N, Khan A . Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report. J Glaucoma. 2009; 18(7):513-20. DOI: 10.1097/IJG.0b013e3181911271. View

4.
Bhardwaj N, Kundu S . Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv. 2010; 28(3):325-47. DOI: 10.1016/j.biotechadv.2010.01.004. View

5.
Seibold L, Sherwood M, Kahook M . Wound modulation after filtration surgery. Surv Ophthalmol. 2012; 57(6):530-50. DOI: 10.1016/j.survophthal.2012.01.008. View